Strategic co-targeting of FOXM1 and EGFR-ERBB2 signaling in ovarian cancer
Sign Up to like & getrecommendations! Published in 2021 at "Gynecologic Oncology"
DOI: 10.1016/s0090-8258(21)01181-1
Abstract: Objectives: Epithelial ovarian cancer (EOC) is a challenging disease due to chemoresistance, and short-term recurrence. Chemoresistance to anti-cancer drugs substantially reduces survival in EOC. In this study, we showed that chemoresistance to lapatinib (a dual… read more here.
Keywords: foxm1 egfr; egfr erbb2; egfr; thiostrepton ... See more keywords